Lenalidomide plus dexamethasone is efficacious in patients with relapsed or refractory multiple myeloma.
Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA 02115, USA. nikhil_munshi@dfci.harvard.edu
Nikhil C
NC
Munshi
Constantine
C
Mitsiades
Paul G
PG
Richardson
Kenneth C
KC
Anderson